Tango Therapeutics (TNGX) Enterprise Value: 2020-2025
Historic Enterprise Value for Tango Therapeutics (TNGX) over the last 6 years, with Sep 2025 value amounting to $781.8 million.
- Tango Therapeutics' Enterprise Value rose 47.02% to $781.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $126.3 million, marking a year-over-year increase of 126.64%. This contributed to the annual value of $74.0 million for FY2024, which is 88.94% down from last year.
- Per Tango Therapeutics' latest filing, its Enterprise Value stood at $781.8 million for Q3 2025, which was up 108.92% from $374.2 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Enterprise Value registered a high of $942.3 million during Q2 2021, and its lowest value of -$78.6 million during Q3 2022.
- For the 3-year period, Tango Therapeutics' Enterprise Value averaged around $372.2 million, with its median value being $503.7 million (2024).
- Per our database at Business Quant, Tango Therapeutics' Enterprise Value spiked by 3,770,259.87% in 2021 and then crashed by 113.62% in 2025.
- Quarterly analysis of 5 years shows Tango Therapeutics' Enterprise Value stood at $470.2 million in 2021, then slumped by 41.91% to $273.2 million in 2022, then skyrocketed by 145.06% to $669.4 million in 2023, then crashed by 88.94% to $74.0 million in 2024, then soared by 47.02% to $781.8 million in 2025.
- Its Enterprise Value was $781.8 million in Q3 2025, compared to $374.2 million in Q2 2025 and -$68.6 million in Q1 2025.